Janus Henderson Group’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.51M | Sell |
1,754,410
-137,525
| -7% | -$510K | ﹤0.01% | 827 |
|
|
2025
Q1 | $6.87M | Sell |
1,891,935
-360,305
| -16% | -$1.31M | ﹤0.01% | 792 |
|
|
2024
Q4 | $12.5M | Sell |
2,252,240
-884,847
| -28% | -$4.93M | 0.01% | 682 |
|
|
2024
Q3 | $33.9M | Sell |
3,137,087
-59,675
| -2% | -$645K | 0.02% | 467 |
|
|
2024
Q2 | $67.1M | Sell |
3,196,762
-682
| -0% | -$14.3K | 0.04% | 321 |
|
|
2024
Q1 | $102M | Buy |
3,197,444
+104,148
| +3% | +$3.32M | 0.06% | 263 |
|
|
2023
Q4 | $62.7M | Buy |
3,093,296
+346,961
| +13% | +$7.03M | 0.04% | 334 |
|
|
2023
Q3 | $35M | Sell |
2,746,335
-92,547
| -3% | -$1.18M | 0.02% | 432 |
|
|
2023
Q2 | $51.3M | Buy |
2,838,882
+961,457
| +51% | +$17.4M | 0.03% | 384 |
|
|
2023
Q1 | $32.3M | Buy |
1,877,425
+411,158
| +28% | +$7.07M | 0.02% | 473 |
|
|
2022
Q4 | $32.6M | Sell |
1,466,267
-1,173,195
| -44% | -$26.1M | 0.02% | 466 |
|
|
2022
Q3 | $21.2M | Buy |
2,639,462
+1,304,414
| +98% | +$10.5M | 0.01% | 659 |
|
|
2022
Q2 | $9.32M | Sell |
1,335,048
-330,363
| -20% | -$2.31M | 0.01% | 707 |
|
|
2022
Q1 | $25.2M | Buy |
1,665,411
+17,488
| +1% | +$264K | 0.01% | 692 |
|
|
2021
Q4 | $36.2M | Buy |
1,647,923
+126,820
| +8% | +$2.78M | 0.02% | 645 |
|
|
2021
Q3 | $41M | Sell |
1,521,103
-18,623
| -1% | -$502K | 0.02% | 609 |
|
|
2021
Q2 | $37.1M | Buy |
1,539,726
+312,329
| +25% | +$7.52M | 0.02% | 647 |
|
|
2021
Q1 | $50.7M | Buy |
1,227,397
+205,486
| +20% | +$8.49M | 0.02% | 546 |
|
|
2020
Q4 | $39.9M | Buy |
+1,021,911
| New | +$39.9M | 0.02% | 596 |
|